Introducing the ISLH & ERN-EuroBloodNet Webinar Series
14/04/2025
Interpretation of Coagulation Lab Tests for Patients on ECMO
The seminar will begin on Apr 17th, 2025 5:00 PM CEST (11 AM ET)
Speaker: Simon Davidson, FIBMS, MPHIL, University College London, UK
Moderator: Karen Moffat, BEd, MSC, ART, FCSMLS(D); HRLMP and McMaster University, Canada
There is no charge to participate in the live webinar.
Overview:
Extracorporeal membrane oxygenation (ECMO) is a type of circulatory life support for patients with severe lung failure.
The use of ECMO has increased worldwide since the pandemic of H1N1 in 2009 and more recently SARS-CoV-2 in 2020 both of which caused severe respiratory failure. ECMO patients experience both increased risk of bleeding and thrombosis. This is due to the pathological insult that damages the lungs, the ECMO circuit, coagulopathy, inflammation and anticoagulation.
ECMO presents unique demands on the coagulation laboratory both in tests required to manage the patients and result interpretation. This is a personal opinion of 20 years ECMO experience as a clinical scientist and a short current review of the literature. It will focus on the laboratory coagulation tests used to manage ECMO patients, including different anticoagulants used, testing frequency and interpretation of the results.
Learning Objectives:
- Anticoagulation with Unfractionated Heparin – variable sensitivity of APTT reagents and Anti-Xa assays.
- Laboratory assays that can aid when monitoring a patient on ECMO.
- Heparin resistance and antithrombin.
Notizie collegate
